Commitments (Tables)

9 Months Ended

Sep. 30, 2021

Commitments And Contingencies Disclosure [Abstract]

Schedule of Manufacturing Commitments and Contingencies

The following table summarizes manufacturing commitments and contingencies as of the period indicated (in thousands):

	September 30, 2021
Molgramostim manufacturer:
Achievement of certain milestones related to validation of API and regulatory approval of molgramostim	$	2,300
Molgramostim nebulizer manufacturer:
Achievement of various development activities and regulatory approval of nebulizer utilized     to administer molgramostim		589
Total manufacturing and other commitments	$	2,889